BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 18483248)

  • 1. Fhit-deficient hematopoietic stem cells survive hydroquinone exposure carrying precancerous changes.
    Ishii H; Mimori K; Ishikawa K; Okumura H; Pichiorri F; Druck T; Inoue H; Vecchione A; Saito T; Mori M; Huebner K
    Cancer Res; 2008 May; 68(10):3662-70. PubMed ID: 18483248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Fhit-ing role in the DNA damage checkpoint response.
    Ishii H; Wang Y; Huebner K
    Cell Cycle; 2007 May; 6(9):1044-8. PubMed ID: 17457056
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fragile gene product, Fhit, in oxidative and replicative stress responses.
    Okumura H; Ishii H; Pichiorri F; Croce CM; Mori M; Huebner K
    Cancer Sci; 2009 Jul; 100(7):1145-50. PubMed ID: 19486340
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Restoration of fragile histidine triad expression restores Chk2 activity in response to ionizing radiation in oral squamous cell carcinoma cells.
    Yutori H; Semba S; Komori T; Yokozaki H
    Cancer Sci; 2008 Mar; 99(3):524-30. PubMed ID: 18167129
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Initiation of genome instability and preneoplastic processes through loss of Fhit expression.
    Saldivar JC; Miuma S; Bene J; Hosseini SA; Shibata H; Sun J; Wheeler LJ; Mathews CK; Huebner K
    PLoS Genet; 2012; 8(11):e1003077. PubMed ID: 23209436
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A knockdown with smoke model reveals FHIT as a repressor of Heme oxygenase 1.
    Boylston JA; Brenner C
    Cell Cycle; 2014; 13(18):2913-30. PubMed ID: 25486479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fhit-Fdxr interaction in the mitochondria: modulation of reactive oxygen species generation and apoptosis in cancer cells.
    Druck T; Cheung DG; Park D; Trapasso F; Pichiorri F; Gaspari M; Palumbo T; Aqeilan RI; Gaudio E; Okumura H; Iuliano R; Raso C; Green K; Huebner K; Croce CM
    Cell Death Dis; 2019 Feb; 10(3):147. PubMed ID: 30770797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fhit deficiency-induced global genome instability promotes mutation and clonal expansion.
    Miuma S; Saldivar JC; Karras JR; Waters CE; Paisie CA; Wang Y; Jin V; Sun J; Druck T; Zhang J; Huebner K
    PLoS One; 2013; 8(11):e80730. PubMed ID: 24244712
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fhit loss in lung preneoplasia: relation to DNA damage response checkpoint activation.
    Cirombella R; Montrone G; Stoppacciaro A; Giglio S; Volinia S; Graziano P; Huebner K; Vecchione A
    Cancer Lett; 2010 May; 291(2):230-6. PubMed ID: 19931269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fhit loss-associated initiation and progression of neoplasia in vitro.
    Karras JR; Schrock MS; Batar B; Zhang J; La Perle K; Druck T; Huebner K
    Cancer Sci; 2016 Nov; 107(11):1590-1598. PubMed ID: 27513973
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fhit and CHK1 have opposing effects on homologous recombination repair.
    Hu B; Wang H; Wang X; Lu HR; Huang C; Powell SN; Huebner K; Wang Y
    Cancer Res; 2005 Oct; 65(19):8613-6. PubMed ID: 16204026
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fhit modulates the DNA damage checkpoint response.
    Ishii H; Mimori K; Inoue H; Inageta T; Ishikawa K; Semba S; Druck T; Trapasso F; Tani K; Vecchione A; Croce CM; Mori M; Huebner K
    Cancer Res; 2006 Dec; 66(23):11287-92. PubMed ID: 17145874
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fhit tumor suppressor: guardian of the preneoplastic genome.
    Pichiorri F; Palumbo T; Suh SS; Okamura H; Trapasso F; Ishii H; Huebner K; Croce CM
    Future Oncol; 2008 Dec; 4(6):815-24. PubMed ID: 19086848
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of FHIT on benzo[a]pyrene-induced tumors and alopecia in mice: chemoprevention by budesonide and N-acetylcysteine.
    Balansky R; D'Agostini F; Ganchev G; Izzotti A; Di Marco B; Lubet RA; Zanesi N; Croce CM; De Flora S
    Proc Natl Acad Sci U S A; 2006 May; 103(20):7823-8. PubMed ID: 16672365
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of FRA16D/WWOX and FRA3B/FHIT genes in hematopoietic malignancies.
    Ishii H; Vecchione A; Furukawa Y; Sutheesophon K; Han SY; Druck T; Kuroki T; Trapasso F; Nishimura M; Saito Y; Ozawa K; Croce CM; Huebner K; Furukawa Y
    Mol Cancer Res; 2003 Nov; 1(13):940-7. PubMed ID: 14638866
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exome-wide single-base substitutions in tissues and derived cell lines of the constitutive Fhit knockout mouse.
    Paisie CA; Schrock MS; Karras JR; Zhang J; Miuma S; Ouda IM; Waters CE; Saldivar JC; Druck T; Huebner K
    Cancer Sci; 2016 Apr; 107(4):528-35. PubMed ID: 26782170
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential cancer therapy with the fragile histidine triad gene: review of the preclinical studies.
    Ishii H; Dumon KR; Vecchione A; Fong LY; Baffa R; Huebner K; Croce CM
    JAMA; 2001 Nov; 286(19):2441-9. PubMed ID: 11712940
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FHIT loss-induced DNA damage creates optimal APOBEC substrates: Insights into APOBEC-mediated mutagenesis.
    Waters CE; Saldivar JC; Amin ZA; Schrock MS; Huebner K
    Oncotarget; 2015 Feb; 6(5):3409-19. PubMed ID: 25401976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The fragile histidine triad/common chromosome fragile site 3B locus and repair-deficient cancers.
    Turner BC; Ottey M; Zimonjic DB; Potoczek M; Hauck WW; Pequignot E; Keck-Waggoner CL; Sevignani C; Aldaz CM; McCue PA; Palazzo J; Huebner K; Popescu NC
    Cancer Res; 2002 Jul; 62(14):4054-60. PubMed ID: 12124341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alterations of FHIT gene and P16 gene in nickel transformed human bronchial epithelial cells.
    Ji WD; Chen JK; Lu JC; Wu ZL; Yi F; Feng SM
    Biomed Environ Sci; 2006 Aug; 19(4):277-84. PubMed ID: 17044645
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.